Deep Science Ventures
Co-founder & CEO, AI that does the reasoning work of drug discovery
How your CV stacks up
Upload your CV to see how well it fits this job role
?%
Co-founder & CEO - AI-Driven Drug Discovery
Join us to build the company that makes AI do the reasoning work of drug discovery—so a small team can do the research of a large one.
We are seeking an experienced founder and operator to join two technical founders as Co-founder & CEO, steering a built, already-used platform through a competitive seed round, Series A, and beyond.
The role is full-time, UK-based, spinning out of Deep Science Ventures (DSV) over the coming months.
THE OPPORTUNITY
Drug discovery still relies on human cognition. Progress hinges on researchers interpreting literature, connecting disparate datasets, and deciding what to test next—bounded by cognitive limits and siloed team structures. This is a global, albeit unscalable, problem that demands transformation.
We are constructing genuine AI-driven reasoning at scale:
- Generates and pressure-tests drug-disease hypotheses
- Validates scientific claims against existing evidence
- Unlocks information currently fragmented across teams and tools
- Converts scattered insights into actionable intelligence for discovery teams
The platform already delivers end-to-end functionality: in a single run, it digested a disease’s whole single-cell research literature, constructed a connected biological map, and returned drug-target hypotheses, each annotated as supported or refuted with evidence traces.
The technical foundation is complete. The liberation of human cognitive bottlenecks is imminent.
Our near-term focus is target validation—helping discovery teams prioritise targets backed by concrete evidence. The engine powers upward toward the ultimate aim: predicting clinical trial outcomes before they commence, explaining the predictions, and securing pharma’s necessary transition to small, milestone-based payments for AI solutions.
We envision a future where progress is governed by idea quality, not by human bandwidth, and monetised akin to how drug development partnerships are now structured.
Reasons to use Rodeo
Start with a chat, not a search bar
Grad scheme, placement, apprenticeship? Not sure what you want yet — that's fine. Your agent talks it through with you and turns "I have no idea" into a shortlist.
It searches the market for you
Every day your agent scans the market matching roles against what actually matters to you, not just keywords on a CV.
Only hits
No noise. No "maybe this fits." Just roles with a clear explanation of why they're right — and where to focus when applying.
Now, we seek a Co-founder & CEO to unite with the two technical founders and forge this culture-changing enterprise.
THE ROLE
A hands-on, relentless, collaborative leadership position awaits. As Co-founder & CEO, you will partner with the founders to build the commercial enterprise from day one.
You will be responsible for:
- Fundraising: Leading a competitive seed round and outlining the path to Series A. This is paramount.
- Commercial engine: developing partnerships, pilots, and paying customers across pharma and biotech.
- Company building: shaping strategy, hiring the founding team, crafting the narrative, and securing board, grant, and academic support.
- Daily operations: address administrative and functional needs, along with setting strategic direction.
Location: Hybrid, UK-centric Commitment: Full-time starting from spin-out Equity: Meaningful founder equity, linked to milestone achievement
REQUIREMENTS
Essential Values
You must embody:
- A burning commitment to galvanise a category-defining startup at the frontier of AI and drug discovery, dramatically transforming traditional practices.
- Impact determination: proactivity, initiative, and a philosophy of first principles to shape what’s truly essential.
- A cultivated entrepreneurial instinct, competent in handling chaotic, adaptable, and demanding circumstances.
- A collaborative mindset, adept at closes alignment with two technical co-founders.
Essential Experience (Non-Negotiable)
Reflect the following experience and expertise:
- Built and/or led a company either as founder or executive.
- Raised venture capital—ideally, led a priced round in a founder capacity.
- A strong existing network in deep-tech, AI, biotech, or health investments.
- Proven commercial and business development experience—partnerships, pilots, paying customers.
- Credibility in technical/scientific discussions—no bluffing; able to engage with the founders in pure science audacity.
- UK-based, available to transition full-time from spin-out.
Get help with your application
Your very own career expert that helps elevate your application to the next level.
Preferred Experience (Desirable)
Ideal but not mandatory highlights:
- Transitioned from AI/scientific programmes to enterprise building, aiming to found your own venture.
- Scaled a company from seed to Series A and beyond.
- Expanded across pharma/biotech business-development networks.
- прямо selling technical/scientific solutions into pharma, biotech, or academic settings in previous roles.
BENEFITS
By joining Deep Science Ventures, you align with a collective of operational pioneers—those who have launched enterprises and bridged academic and merchant imperatives within the world’s most prestigious institutions.
Spin-out advantages include:
- Genuine co-founder-equity, with fortunes tied to milestone progression.
- Unparalleled venture-building tools, resources, and frameworks—sculpting world-changing companies from ground zero.
- Unlimited access to DSV’s label-to-risk investor-advisor network.
- A ready-to-pitch product line with strong technical differentiation, backing your market entry and cap-raising priorities.
- Ongoing post-spin-out committed support: fundraising facilitation, commercial binding, recruitment, and team building.
ABOUT DEEP SCIENCE VENTURES
Deep Science Ventures exists to enact a world where both humanity and the planet thrive.
Our Operation
Differs by embracing a unique venture creation lifecycle—followed by capital injection—and prioritises first-principles solutions. Combined with the greatest theory-adherents globally, we design ventures to disrupt:
- Pharmaceuticals
- Climate Initiatives
- Agricultural Transitions
- Computational Sciences
Our port-folio of 50+ such companies has aggregated a valuation of $700m, propelled by rigorous first-principles productivity and alliances with the most prestigious educational and commercial entities.
“It took my CV and asked me questions relevant to understanding what kind of jobs to suggest for me. Suggestions were almost perfect. Jobs were exactly what I’ve been looking for.”
Jessica, London
Skills
Location